Hypertension, Pulmonary: Clinical Trials

1,612 trials for Hypertension, Pulmonary, newest first

ClinicalTrials Daily  ·  Areas  ·  Conditions  ·  Drugs  ·  Sponsors  ·  

782 completed, 216 unknown, 200 recruiting, 174 terminated. 339 Not applicable, 290 Phase 2, 216 Phase 3, 151 Phase 1, 125 Phase 4.

By phase and status

PhaseTrialsStatus
Not applicable339Completed 150, Unknown 73, Recruiting 49, Not yet recruiting 21, Terminated 16, Withdrawn 15, Active not recruiting 9, Enrolling by invitation 4, Suspended 2
Phase 2290Completed 139, Terminated 59, Recruiting 27, Withdrawn 24, Unknown 18, Not yet recruiting 15, Active not recruiting 8
Phase 3216Completed 109, Terminated 43, Recruiting 18, Unknown 16, Withdrawn 14, Active not recruiting 10, Not yet recruiting 4, Enrolling by invitation 1, Suspended 1
Phase 1151Completed 94, Terminated 15, Recruiting 13, Withdrawn 13, Unknown 8, Not yet recruiting 6, Active not recruiting 2
Phase 4125Completed 59, Terminated 27, Unknown 12, Recruiting 10, Withdrawn 9, Not yet recruiting 5, Active not recruiting 3
Early Phase 119Completed 5, Terminated 5, Recruiting 3, Unknown 3, Not yet recruiting 2, Withdrawn 1

Follow Hypertension, Pulmonary: new trials by email Literature Review of Hypertension, Pulmonary trials Research Report on Hypertension, Pulmonary

Trials newest first · largest first

Tick up to 5 trials to compare them side by side (eligibility, arms, endpoints, adverse events) in a Literature Matrix.

TrialPhaseStatusSponsorEnrollmentStartUpdated
A Multiple Dose Study to Investigate Safety, Tolerability and Pharmacokinetics of MN-08 Tablets
MN-08 24 mg/day, MN-08 60 mg/day - Pulmonary Arterial Hypertension
Phase 1Not yet recruitingGuangzhou Magpie Pharmaceuticals Co., Ltd.162027-09-012026-09-14
Clinical Trial of 2-HOBA in Pulmonary Arterial Hypertension
2-HOBA - Pulmonary Arterial Hypertension
Phase 2Not yet recruitingVanderbilt University Medical Center122027-05-012026-11-10
An Open-Label Extension Study to Evaluate Inhaled Treprostinil SMI in Participants With Pulmonary Hypertension Associated With Chronic Obstructive Pulmonary Disease (PH-COPD)
treprostinil SMI (treprostinil inhalation spray) - Pulmonary Hypertension Associated With Chronic Obstructive Pulmonary Disease
Phase 2 / Phase 3Not yet recruitingUnited Therapeutics4002027-03-012026-11-06
What is the Role of the Exposome in Pulmonary Hypertension
Questionnaires, Samples - Pulmonary Arterial Hypertension (PAH), Chronic Thromboembolic Pulmonary Hypertension (CTEPH)
Not yet recruitingPoitiers University Hospital1502027-01-012026-07-22
GLP-1/GIP Receptor Agonists in Obesity-Related HFpEF: The GLIDE-HF Registry
GLP-1 / GIP receptor agonist - Heart Failure With Preserved Ejection Fraction, Obesity
Not yet recruitingMiedziowe Centrum Zdrowia SA1502027-01-012026-08-26
Right Heart and Lung Blood Flow During Exercise (RIGHT-NET 2.0)
Right Ventricular Dysfunction, Cardiopulmonary Diseases
Not yet recruitingIRCCS SYNLAB SDN20002027-01-012026-10-01
Bridge to Lung Transplant With Trans-septal Extra-corporeal Membrane Oxygenation (ECMO) for Right Heart Failure From Pulmonary Hypertension
Protek Solo Transseptal Cannula - Lung Transplant, Pulmonary Hypertension
Phase 1RecruitingMayo Clinic42026-12-112026-07-31
Development and Validation of a Chinese Quality of Life Scale for Pulmonary Arterial Hypertension
Questionnaire Assessment - Pulmonary Arterial Hypertension (PAH), Quality of Life
Not yet recruitingChinese Pulmonary Vascular Disease Research Group3002026-12-012026-10-27
Sotatercept in the Treatment of Methamphetamine-Associated Pulmonary Arterial Hypertension
Sotatercept - Pulmonary Arterial Hypertension (PAH), Methamphetamine Use Disorder
Phase 4Not yet recruitingOregon Health and Science University202026-12-012026-11-16
A Clinical Study of MK-7962 in Chinese Participants With Pulmonary Arterial Hypertension (MK-7962-022)
Sotatercept - Hypertension, Pulmonary
Phase 4Not yet recruitingMerck Sharp & Dohme LLC402026-11-302026-10-28
A Clinical Study of Sotatercept (MK-7962) in People With Combined Postcapillary and Precapillary Pulmonary Hypertension and Heart Failure With Preserved Ejection Fraction (MK-7962-041)
Sotatercept, Placebo - Pulmonary Hypertension
Phase 3Not yet recruitingMerck Sharp & Dohme LLC3522026-11-262026-11-16
[18F]ZDG2 First-in-Human PET Imaging in PAH
[18F]ZDG2- Single Dose - Pulmonary Artery Hypertension
Early Phase 1Not yet recruitingThe Methodist Hospital Research Institute202026-11-142026-11-12
A Study of Opsynvi in Adults Participants With Pulmonary Arterial Hypertension in Korea
Pulmonary Arterial Hypertension
Not yet recruitingJanssen Korea, Ltd., Korea3332026-11-022026-11-03
Understanding the Effects of Pulmonary Arterial Hypertension on Lean Muscle Mass-Substudy
Measurement of oxyhemoglobin and deoxyhemoglobin concentration pre and post- exercise at baseline and Week 12. Measurement of time to recovery of oxyhemglobin post-exercise at baseline and at Week 12., Blood draw - Pulmonary Arterial Hypertension
Not applicableRecruitingUniversity of Pennsylvania202026-11-022026-11-10
Hyperpolarized Xenon MRI in Adults With Pulmonary Hypertension in Interstitial Lung Disease and Systemic Sclerosis
Hyperpolarized 129 Xenon Gas - Interstitial Lung Disease, Pulmonary Hypertension
Phase 2Not yet recruitingBastiaan Driehuys512026-11-012026-09-15
TEPH: Telaglenastat Efficacy in Pulmonary Hypertension
Telaglenastat - Pulmonary Hypertension
Phase 1 / Phase 2Not yet recruitingChan, Stephen, MD, PhD282026-11-012026-09-17
Home-based Inspiratory Muscle Training in Pulmonary Hypertension
Inspiratory muscle training, Sham inspiratory muscle training - Pulmonary Arterial Hypertension, Chronic Thromboembolic Pulmonary Hypertension
Not applicableNot yet recruitingUniversidad Complutense de Madrid402026-11-012026-11-04
Study of Treprostinil Administered Via Soft Mist Inhaler (SMI) in Participants With Pulmonary Hypertension Associated With Chronic Obstructive Pulmonary Disease (PH-COPD)
treprostinil SMI (treprostinil inhalation spray), Placebo (placebo inhalation spray) - Pulmonary Hypertension Associated With Chronic Obstructive Pulmonary Disease
Phase 2Not yet recruitingUnited Therapeutics402026-11-012026-11-06
Colchicine in Pulmonary Artery Hypertension Patients
Colchicine 0.5 MG Oral Tablet - Pulmonary Hypertension
Phase 2Not yet recruitingAin Shams University602026-10-312026-10-30
Dopamine vs. Norepinephrine for Hypotension in Neonates With Pulmonary Hypertension (DONE)
Dopamine administration, Norepinephrine - Hypotension and Shock, Pulmonary Hypertension of the Newborn (PPHN)
Phase 4RecruitingUniversity of California, Davis302026-10-302026-08-18

Showing 20 of 1612. Sign in to see all of them.

Narrower conditions

Pulmonary Arterial Hypertension (694)  ·  Familial Primary Pulmonary Hypertension (100)  ·  Heart Failure (88)  ·  Pulmonary Disease, Chronic Obstructive (72)  ·  Lung Diseases, Interstitial (59)  ·  Hypoxia (42)  ·  Heart Defects, Congenital (40)  ·  Motor Activity (40)  ·  Persistent Fetal Circulation Syndrome (40)  ·  Lung Diseases (36)  ·  Hypertension (34)  ·  Scleroderma, Systemic (34)  ·  Altitude Sickness (32)  ·  Anemia, Sickle Cell (30)

Broader conditions

Respiratory Tract Diseases (1600)  ·  Lung Diseases (1576)  ·  Cardiovascular Diseases (1052)  ·  Vascular Diseases (1022)  ·  Hypertension (998)  ·  Pathological Conditions, Signs and Symptoms (262)  ·  Heart Diseases (198)  ·  Pathologic Processes (185)  ·  Congenital, Hereditary, and Neonatal Diseases and Abnormalities (181)  ·  Disease Attributes (99)  ·  Respiration Disorders (97)  ·  Chronic Disease (83)  ·  Signs and Symptoms (78)  ·  Congenital Abnormalities (77)

Interventions

Sildenafil Citrate (86)  ·  treprostinil (65)  ·  Bosentan (45)  ·  Iloprost (40)  ·  ambrisentan (39)  ·  Tadalafil (34)  ·  riociguat (31)  ·  macitentan (26)  ·  ACE-011 (23)  ·  selexipag (18)  ·  Blood Specimen Collection (16)  ·  Exercise (16)  ·  Epoprostenol (14)  ·  Echocardiography (13)  ·  Nitric Oxide (12)

Sponsors

Actelion (72)  ·  United Therapeutics (62)  ·  University of Zurich (53)  ·  Bayer (45)  ·  Medical University of Graz (23)  ·  Pfizer's Upjohn has merged with Mylan to form Viatris Inc. (23)  ·  Assistance Publique - Hôpitaux de Paris (22)  ·  National Heart, Lung, and Blood Institute (NHLBI) (20)  ·  Heidelberg University (18)  ·  Merck Sharp & Dohme LLC (18)  ·  Mayo Clinic (17)  ·  Assiut University (15)  ·  GlaxoSmithKline (14)  ·  Pfizer (14)  ·  University of Giessen (14)

Countries

United States (627)  ·  Germany (213)  ·  France (181)  ·  United Kingdom (179)  ·  Canada (147)  ·  China (139)  ·  Spain (127)  ·  Italy (125)  ·  Belgium (107)  ·  Austria (99)  ·  Switzerland (93)  ·  Australia (91)  ·  Poland (88)  ·  Israel (87)  ·  Netherlands (83)

Top investigators

Horst Olschewski, MD (18)  ·  Silvia Ulrich, Prof. Dr. (17)  ·  Silvia Ulrich, Prof. (15)  ·  Ashika Ahmed, MD (8)  ·  Rodrigo Hoyos (7)  ·  Silvia Ulrich (7)  ·  Rajan Saggar, MD (6)  ·  Silvia Ulrich, MD (6)  ·  Steeve Provencher, MD, MSc (6)

Results publications

PMID 16982941, PMID 26589907, PMID 27162632, PMID 20175775, PMID 24578332, PMID 24916507, PMID 27263466, PMID 34353714, PMID 17418297, PMID 18277824, PMID 20585012, PMID 21680644, PMID 22280813, PMID 22281797, PMID 22354598, PMID 23164592, PMID 23403476, PMID 23883377, PMID 23883378, PMID 23883383, PMID 25372980, PMID 25496504, PMID 26113687, PMID 26135803, PMID 26231884, PMID 26308684, PMID 26320113, PMID 27067478, PMID 27326239, PMID 27444506, PMID 27457511, PMID 28775050, PMID 29447737, PMID 29501590, PMID 29531764, PMID 30545968, PMID 31109190, PMID 31487545, PMID 31538282, PMID 31722151, PMID 31908813, PMID 32974687, PMID 33651671, PMID 34379314, PMID 34727317, PMID 34848133, PMID 35256218, PMID 35628896, PMID 35819570, PMID 35990987

NIH funding

2018 (24), 2023 (16), 2025 (10), 2008 (7), 2014 (7), 2015 (7), 2017 (7), 2016 (6), U10HD021385 (6), U10HD027880 (6), 2009 (5), U10HD027904 (5), U10HD034216 (5), M01RR000070 (4), M01RR000750 (4)